@article{4308f0e796a145fd975b09d0c93cef02,
title = "Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts",
author = "Zeidan, \{Amer M.\} and Uwe Platzbecker and Guillermo Garcia-Manero and Sekeres, \{Mikkael A.\} and Pierre Fenaux and DeZern, \{Amy E.\} and Greenberg, \{Peter L.\} and Savona, \{Michael R.\} and Jurcic, \{Joseph G.\} and Verma, \{Amit K.\} and Mufti, \{Ghulam J.\} and Rena Buckstein and Valeria Santini and Shetty, \{Jeevan K.\} and Rodrigo Ito and Jennie Zhang and George Zhang and Xianwei Ha and Backstrom, \{Jay T.\} and Komrokji, \{Rami S.\}",
note = "Funding Information: This study was supported by Celgene , a Bristol-Myers Squibb Company , in collaboration with Acceleron Pharma Inc, a subsidiary of Merck \& Co, Inc, Rahway, NJ, USA and by Bloodwise UK grants 10024 and 14017 (G.J.M.) and Cancer Research UK grant A22324 (G.J.M.). ",
year = "2022",
month = nov,
day = "17",
doi = "10.1182/blood.2022016171",
language = "English (US)",
volume = "140",
pages = "2170--2174",
journal = "Blood",
issn = "0006-4971",
publisher = "Elsevier B.V.",
number = "20",
}